Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE for Postmenopause: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE was used for Postmenopause.

Most Reported Side Effects for ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE

Side Effect Reports % Deaths Hosp.
Drug ineffective 178 10.5% 0 10
Hot flush 156 9.2% 0 6
Malaise 135 7.9% 0 26
Feeling abnormal 123 7.2% 1 14
Insomnia 121 7.1% 0 10
Off label use 119 7.0% 1 6
Intentional product misuse 95 5.6% 1 9
Product prescribing error 84 4.9% 0 9
Vaginal haemorrhage 77 4.5% 0 4
Headache 72 4.2% 0 9
Pain 63 3.7% 0 11
Anxiety 62 3.6% 0 8
Depression 61 3.6% 1 7
Hyperhidrosis 61 3.6% 0 7
Fatigue 55 3.2% 0 8

Other Indications for ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE

Hot flush (272) Menopause (220) Menopausal symptoms (197) Hormone replacement therapy (149) Night sweats (45) Osteoporosis (29) Product used for unknown indication (27) Hormone therapy (25) Hyperhidrosis (23) Vulvovaginal dryness (22)

Other Drugs Used for Postmenopause

ESTRADIOL (115) MINIVELLE (50) ESTROGENS, CONJUGATED (34) DENOSUMAB (16) ESTRADIOL\NORETHINDRONE (14) PROGESTERONE (13) ESTRADIOL\LEVONORGESTREL (6) PRASTERONE (6) RIBOCICLIB (6) ANASTROZOLE (5)

Related Pages

ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE Full Profile All Postmenopause Drugs ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE Demographics ESTROGENS, CONJUGATED\MEDROXYPROGESTERONE Timeline